Transforming growth factor β receptor 1 is a new candidate prognostic biomarker after acute myocardial infarction

BMC Medical Genomics

Volumn 4, Issue , 2011, Pages

  Devaux, Yvan ^a   Bousquenaud, Melanie ^a   Rodius, Sophie ^a   Marie, Pierre Yves ^b   Maskali, Fatiha ^b   Zhang, Lu ^a   Azuaje, Francisco ^a   Wagner, Daniel R ^a,c  

^a LUXEMBOURG INSTITUTE OF HEALTH   (Luxembourg)

^b Nancyclotep Experimental Imaging Platform   (France)

^c Centre Hospitalier   (Luxembourg)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MESSENGER RNA; NITRATE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA1; TROPONIN T; ANGIOGENIC PROTEIN; BIOLOGICAL MARKER; PROTEIN SERINE THREONINE KINASE; TGF BETA TYPE I RECEPTOR; TGF-BETA TYPE I RECEPTOR; TGFB1 PROTEIN, HUMAN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ADULT; AGE; AGED; ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE MARKER; ECHOCARDIOGRAPHY; FEMALE; GENDER; GENE; GENE IDENTIFICATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE REPERFUSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; NONHUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN PROTEIN INTERACTION; RAT; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1 GENE; UPREGULATION; VALIDATION STUDY; ACUTE DISEASE; BLOOD; BLOOD CELL; GENE EXPRESSION PROFILING; GENETICS; HEART INFARCTION; HEART MUSCLE; HEART VENTRICLE REMODELING; METABOLISM; MIDDLE AGED; MULTIGENE FAMILY; PATHOPHYSIOLOGY; REPRODUCIBILITY;

RATTUS;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; ANGIOGENIC PROTEINS; BIOLOGICAL MARKERS; BLOOD CELLS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MALE; MIDDLE AGED; MULTIGENE FAMILY; MYOCARDIAL INFARCTION; MYOCARDIUM; PROGNOSIS; PROTEIN INTERACTION MAPS; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; REPRODUCIBILITY OF RESULTS; TRANSFORMING GROWTH FACTOR BETA1; VENTRICULAR REMODELING;

EID: 82655180611     PISSN: None     EISSN: 17558794     Source Type: Journal    
DOI: 10.1186/1755-8794-4-83     Document Type: Article

References (46)

1. The timing of development and subsequent clinical course of heart failure after a myocardial infarction. Torabi A, Cleland JG, Khan NK, Loh PH, Clark AL, Alamgir F, Caplin JL, Rigby AS, Goode K, Eur Heart J 2008 29 859 870 10.1093/eurheartj/ehn096 18353754 (Pubitemid 351499497)
2. Declining in-hospital mortality and increasing heart failure incidence in elderly patients with first myocardial infarction. Ezekowitz JA, Kaul P, Bakal JA, Armstrong PW, Welsh RC, McAlister FA, J Am Coll Cardiol 2009 53 13 20 10.1016/j.jacc.2008.08.067 19118718
3. Prevention of heart failure: a scientific statement from the American Heart Association Councils on Epidemiology and Prevention, Clinical Cardiology, Cardiovascular Nursing, and High Blood Pressure Research; Quality of Care and Outcomes Research Interdisciplinary Working Group; and Functional Genomics and Translational Biology Interdisciplinary Working Group. Schocken DD, Benjamin EJ, Fonarow GC, Krumholz HM, Levy D, Mensah GA, Narula J, Shor ES, Young JB, Hong Y, Circulation 2008 117 2544 2565 10.1161/CIRCULATIONAHA.107.188965 18391114 (Pubitemid 351670463)
4. Prediction of 6 months left ventricular dilatation after myocardial infarction in relation to cardiac morbidity and mortality. Application of a new dilatation model to GISSI-3 data. de Kam PJ, Nicolosi GL, Voors AA, van den Berg MP, Brouwer J, van Veldhuisen DJ, Barlera S, Maggioni AP, Giannuzzi P, Temporelli PL, Latini R, van Gilst WH, Eur Heart J 2002 23 536 542 10.1053/euhj.2001.2820 11922643 (Pubitemid 35192200)
5. What does systems biology mean for biomarker discovery? Azuaje F, Exp Opin Med Diagn 2009 4 1 10
6. Integrative pathway-centric modeling of ventricular dysfunction after myocardial infarction. Azuaje F, Devaux Y, Wagner DR, PLoS One 2010 5 9661 10.1371/journal.pone.0009661 20300185
7. Integrated protein network and microarray analysis to identify potential biomarkers after myocardial infarction. Devaux Y, Azuaje F, Vausort M, Yvorra C, Wagner DR, Funct Integr Genomics 2010 10 329 337 10.1007/s10142-010-0169-0 20414696
8. Prognostic transcriptional association networks: a new supervised approach based on regression trees. Nepomuceno-Chamorro I, Azuaje F, Devaux Y, Nazarov PV, Muller A, Aguilar-Ruiz JS, Wagner DR, Bioinformatics 2011 27 252 258 10.1093/bioinformatics/btq645 21098433
9. Microvascular obstruction and left ventricular remodeling early after acute myocardial infarction. Gerber BL, Rochitte CE, Melin JA, McVeigh ER, Bluemke DA, Wu KC, Becker LC, Lima JA, Circulation 2000 101 2734 2741 10851212 (Pubitemid 30390578)
10. Impact of microvascular dysfunction on left ventricular remodeling and long-term clinical outcome after primary coronary angioplasty for acute myocardial infarction. Bolognese L, Carrabba N, Parodi G, Santoro GM, Buonamici P, Cerisano G, Antoniucci D, Circulation 2004 109 1121 1126 10.1161/01.CIR. 0000118496.44135.A7 14967718 (Pubitemid 38332616)
11. Functional recovery after acute myocardial infarction: comparison between angiography, electrocardiography, and cardiovascular magnetic resonance measures of microvascular injury. Nijveldt R, Beek AM, Hirsch A, Stoel MG, Hofman MB, Umans VA, Algra PR, Twisk JW, van Rossum AC, J Am Coll Cardiol 2008 52 181 189 10.1016/j.jacc.2008.04.006 18617066 (Pubitemid 351915778)
12. Transcriptional network governing the angiogenic switch in human pancreatic cancer. Abdollahi A, Schwager C, Kleeff J, Esposito I, Domhan S, Peschke P, Hauser K, Hahnfeldt P, Hlatky L, Debus J, Peters JM, Friess H, Folkman J, Huber PE, Proc Natl Acad Sci USA 2007 104 12890 12895 10.1073/pnas.0705505104 17652168 (Pubitemid 47255250)
13. Transcriptional networks characterize ventricular dysfunction after myocardial infarction: A proof-of-concept investigation. Azuaje F, Devaux Y, Vausort M, Yvorra C, Wagner DR, J Biomed Inform 2010 43 812 819 10.1016/j.jbi.2010.05.012 20580939
14. An open-access long oligonucleotide microarray resource for analysis of the human and mouse transcriptomes. Le Brigand K, Russell R, Moreilhon C, Rouillard JM, Jost B, Amiot F, Magnone V, Bole-Feysot C, Rostagno P, Virolle V, Defamie V, Dessen P, Williams G, Lyons P, Rios G, Mari B, Gulari E, Kastner P, Gidrol X, Freeman TC, Barbry P, Nucleic Acids Res 2006 34 87 10.1093/nar/gkl485 16855282
15. Genomics, transcriptional profiling, and heart failure. Margulies KB, Bednarik DP, Dries DL, J Am Coll Cardiol 2009 53 1752 1759 10.1016/j.jacc.2008. 12.064 19422981
16. Correlation of Peripheral-Blood Gene Expression With the Extent of Coronary Artery Stenosis. Wingrove JA, Daniels SE, Sehnert AJ, Tingley W, M E, Rosenberger S, Buellesfeld L, Grube E, Newby LK, Ginsburg GS, Kraus WE, Circ Cardiovasc Genet 2008 1 31 38 10.1161/CIRCGENETICS.108.782730 20031539
17. Gene expression profiles in peripheral blood mononuclear cells of chronic heart failure patients. Cappuzzello C, Napolitano M, Arcelli D, Melillo G, Melchionna R, Di Vito L, Carlini D, Silvestri L, Brugaletta S, Liuzzo G, Crea F, Capogrossi MC, Physiol Genomics 2009 38 233 240 10.1152/physiolgenomics.90364. 2008 19336532
18. Association between transforming growth factor-[beta]1 and left ventricular mass and diameter in hypertensive patients. Almendral JL, Shick V, Rosendorff C, Atlas SA, J Am Soc Hypertens 2010 4 135 141 10.1016/j.jash.2010. 02.007 20470998
19. 21 Reflect Left Ventricular Remodeling in Aortic Stenosis. Villar AV, Cobo M, Llano M, Montalvo C, Gonzalez-Vilchez F, Martin-Duran R, Hurle MA, Nistal JF, PLoS One 2009 4 8476 10.1371/journal.pone.0008476 20041033
20. Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. Zethelius B, Berglund L, Sundstrom J, Ingelsson E, Basu S, Larsson A, Venge P, Arnlov J, N Engl J Med 2008 358 2107 2116 10.1056/NEJMoa0707064 18480203 (Pubitemid 351679597)
21. The limitations of risk factors as prognostic tools. Ware JH, N Engl J Med 2006 355 2615 2617 10.1056/NEJMp068249 17182986 (Pubitemid 44969120)
22. Transcriptomic biomarkers for individual risk assessment in new-onset heart failure. Heidecker B, Kasper EK, Wittstein IS, Champion HC, Breton E, Russell SD, Kittleson MM, Baughman KL, Hare JM, Circulation 2008 118 238 246 10.1161/CIRCULATIONAHA.107.756544 18591436
23. Plasma Biomarkers That Reflect Determinants of Matrix Composition Identify the Presence of Left Ventricular Hypertrophy and Diastolic Heart Failure. Zile MR, Desantis SM, Baicu CF, Stroud RE, Thompson SB, McClure CD, Mehurg SM, Spinale FG, Circ Heart Fail 2011 4 246 256 10.1161/CIRCHEARTFAILURE. 110.958199 21350055
24. Multimarker risk model containing troponin-T, interleukin 10, myeloperoxidase and placental growth factor predicts long-term cardiovascular risk after non-ST-segment elevation acute coronary syndrome. Oemrawsingh RM, Lenderink T, Akkerhuis KM, Heeschen C, Baldus S, Fichtlscherer S, Hamm CW, Simoons ML, Boersma E, Heart 2011 97 1061 1066 10.1136/hrt.2010.197392 21558475
25. Pivotal role of cardiomyocyte TGF-beta signaling in the murine pathological response to sustained pressure overload. Koitabashi N, Danner T, Zaiman AL, Pinto YM, Rowell J, Mankowski J, Zhang D, Nakamura T, Takimoto E, Kass DA, J Clin Invest 2011 126 2301 2312
26. Transforming growth factor-beta: vasculogenesis, angiogenesis, and vessel wall integrity. Pepper MS, Cytokine Growth Factor Rev 1997 8 21 43 10.1016/S1359-6101(96)00048-2 9174661 (Pubitemid 27214687)
27. Transforming growth factor (TGF)-[beta] signaling in cardiac remodeling. Dobaczewski M, Chen W, Frangogiannis NG, J Mol Cell Cardiol 2011 51 600 606 10.1016/j.yjmcc.2010.10.033 21059352
28. Transforming Growth Factor-{beta} Blockade Down-Regulates the Renin-Angiotensin System and Modifies Cardiac Remodeling after Myocardial Infarction. Ellmers LJ, Scott NJA, Medicherla S, Pilbrow AP, Bridgman PG, Yandle TG, Richards AM, Protter AA, Cameron VA, Endocrinology 2008 149 5828 5834 10.1210/en.2008-0165 18653707
29. Essential Role of Smad3 in Infarct Healing and in the Pathogenesis of Cardiac Remodeling. Bujak M, Ren G, Kweon HJ, Dobaczewski M, Reddy A, Taffet G, Wang X-F, Frangogiannis NG, Circulation 2007 116 2127 2138 10.1161/ CIRCULATIONAHA.107.704197 17967775 (Pubitemid 350060350)
30. 2. Kapur NK, Circ Heart Fail 2011 4 5 7 10.1161/CIRCHEARTFAILURE.110.960054 21245455
31. Long-Term Localized High-Frequency Electric Stimulation Within the Myocardial Infarct: Effects on Matrix Metalloproteinases and Regional Remodeling. Mukherjee R, Rivers WT, Ruddy JM, Matthews RG, Koval CN, Plyler RA, Chang EI, Patel RK, Kern CB, Stroud RE, Spinale FG, Circulation 2010 122 20 32 10.1161/CIRCULATIONAHA.110.936872 20566951
32. Targeted inhibition of activin receptor-like kinase 5 signaling attenuates cardiac dysfunction following myocardial infarction. Tan SM, Zhang Y, Connelly KA, Gilbert RE, Kelly DJ, Am J Physiol-Heart and Circ Physiol 2010 298 1415 H1425 10.1152/ajpheart.01048.2009
33. Postinfarction Gene Therapy Against Transforming Growth Factor-{beta} Signal Modulates Infarct Tissue Dynamics and Attenuates Left Ventricular Remodeling and Heart Failure. Okada H, Takemura G, Kosai K-i, Li Y, Takahashi T, Esaki M, Yuge K, Miyata S, Maruyama R, Mikami A, Minatoguchi S, Fujiwara T, Fujiwara H, Circulation 2005 111 2430 2437 10.1161/01.CIR.0000165066.71481.8E 15867170 (Pubitemid 40696130)
34. 2 therapies in cancer and fibrosis. Hawinkels LJAC, ten Dijke P, Growth Factors 2011 29 140 152 10.3109/08977194. 2011.595411 21718111
35. A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Loeys BL, Chen J, Neptune ER, Judge DP, Podowski M, Holm T, Meyers J, Leitch CC, Katsanis N, Sharifi N, Xu FL, Myers LA, Spevak PJ, Cameron DE, De Backer J, Hellemans J, Chen Y, Davis EC, Webb CL, Kress W, Coucke P, Rifkin DB, De Paepe AM, Dietz HC, Nat Genet 2005 37 275 281 10.1038/ng1511 15731757 (Pubitemid 41716254)
36. Aneurysm syndromes caused by mutations in the TGF-beta receptor. Loeys BL, Schwarze U, Holm T, Callewaert BL, Thomas GH, Pannu H, De Backer JF, Oswald GL, Symoens S, Manouvrier S, Roberts AE, Faravelli F, Greco MA, Pyeritz RE, Milewicz DM, Coucke PJ, Cameron DE, Braverman AC, Byers PH, De Paepe AM, Dietz HC, N Engl J Med 2006 355 788 798 10.1056/NEJMoa055695 16928994 (Pubitemid 44285584)
37. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP, Proc Natl Acad Sci USA 2005 102 15545 15550 10.1073/pnas.0506580102 16199517 (Pubitemid 41528093)
38. The Entrez-Gene Database. http://www.ncbi.nlm.nih.gov/entrez
39. Development of human protein reference database as an initial platform for approaching systems biology in humans. Peri S, Navarro JD, Amanchy R, Kristiansen TZ, Jonnalagadda CK, Surendranath V, Niranjan V, Muthusamy B, Gandhi TK, Gronborg M, Ibarrola N, Deshpande N, Shanker K, Shivashankar HN, Rashmi BP, Ramya MA, Zhao Z, Chandrika KN, Padma N, Harsha HC, Yatish AJ, Kavitha MP, Menezes M, Choudhury DR, Suresh S, Ghosh N, Saravana R, Chandran S, Krishna S, Joy M, Anand SK, Madavan V, Joseph A, Wong GW, Schiemann WP, Constantinescu SN, Huang L, Khosravi-Far R, Steen H, Tewari M, Ghaffari S, Blobe GC, Dang CV, Garcia JG, Pevsner J, Jensen ON, Roepstorff P, Deshpande KS, Chinnaiyan AM, Hamosh A, Chakravarti A, Pandey A, Genome Res 2003 13 2363 2371 10.1101/gr.1680803 14525934 (Pubitemid 37266003)
40. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T, Genome Res 2003 13 2498 2504 10.1101/gr.1239303 14597658 (Pubitemid 37428274)
41. An automated method for finding molecular complexes in large protein interaction networks. Bader GD, Hogue CW, BMC Bioinformatics 2003 4 2 10.1186/1471-2105-4-2 12525261 (Pubitemid 38751268)
42. Initial infarct size predicts subsequent cardiac remodeling in the rat infarct model: an in vivo serial pinhole gated SPECT study. Maskali F, Franken PR, Poussier S, Tran N, Vanhove C, Boutley H, Le Gall H, Karcher G, Zannad F, Lacolley P, Marie PY, J Nucl Med 2006 47 337 344 16455641 (Pubitemid 46780900)
43. High-resolution simultaneous imaging of SPECT, PET, and MRI tracers on histologic sections of myocardial infarction. Maskali F, Poussier S, Marie PY, Tran N, Antunes L, Olivier P, Plenat F, Maitrejean S, Zannad F, Karcher G, J Nucl Cardiol 2005 12 229 230 10.1016/j.nuclcard.2004.12.296 15812379 (Pubitemid 40450774)
44. ECG-triggered (18)F-fluorodeoxyglucose positron emission tomography imaging of the rat heart is dramatically enhanced by acipimox. Poussier S, Maskali F, Tran N, Person C, Maureira P, Boutley H, Karcher G, Lacolley P, Regnault V, Fay R, Marie PY, Eur J Nucl Med Mol Imaging 2010 37 1745 1750 10.1007/s00259-010-1418-0 20393712
45. Automatic quantification of ejection fraction from gated myocardial perfusion SPECT. Germano G, Kiat H, Kavanagh PB, Moriel M, Mazzanti M, Su HT, Van Train KF, Berman DS, J Nucl Med 1995 36 2138 2147 7472611
46. Data mining in bioinformatics using Weka. Frank E, Hall M, Trigg L, Holmes G, Witten IH, Bioinformatics 2004 20 2479 2481 10.1093/bioinformatics/ bth261 15073010 (Pubitemid 39429925)